AbbVie Stock News

AbbVie offers reliable income and solid growth prospects. Bristol Myers Squibb is a stable dividend stock to buy and hold.

Times of higher uncertainty and elevated market volatility can provide investors with excellent opportunities to start building a dividend portfolio. The dividend portfolio I will present in today's article provides investors with broad diversification across sectors, with no sector accounting for more than 18% of the overall portfolio. This dividend portfolio delivers a Weighted Average Divide...

10,000 boomers are reaching retirement age every day. The 4% rule for retirement withdrawals may not always work due to sequence risk and market fluctuations. Building a dividend income snowball can provide a more stable retirement income, with 2 high-yielding recession-proof stock picks recommended.

Seasoned investors tend to closely follow the ups and downs of the market.

ATLANTA--(BUSINESS WIRE)---- $ABBV #7_milliion_Americans_afflicted_with_Bipolar_disorder--Alzamend Neuro Partners with Mass. General Hosp. for Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate for BD.

ATLANTA--(BUSINESS WIRE)---- $ABBV #Alzamend--Alzamend Neuro Partners with Massachusetts General Hosp. for Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate.

The S&P 500 index came close to correction territory on Aug. 2, after falling about 5.7% from a peak it reached in mid-July. With drugs that some of us can't live without, Bristol Myers Squibb hasn't lowered its dividend payment in 25 years.

The tech rally is losing steam as economic indicators, including rising unemployment and weak manufacturing data, suggest increasing recession risks. Investors are shifting focus from high-growth tech to value stocks, driven by concerns over valuation and a slowing economic outlook. In this uncertain environment, finding quality investments with solid balance sheets and growth potential is key ...